TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23019142

Group type: EXPERIMENTAL
Intervention: Imagining a negative encounter followed by a positive encounter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Purely positive interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mixed-valence imagery task
Number of subjects: 0
Study: 19342020

Group type: EXPERIMENTAL
Intervention: hCG supplementation (250 microg on day of P initiation, day of embryo transfer, and 6 days later)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group (standard protocol for endometrial preparation)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: hCG supplementation
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 165
Study: 18581464

Group type: EXPERIMENTAL
Intervention: Nifedipine (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Carvedilol (group B)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ramipril added to partial responders
Number of subjects: 50
Study: 16634036

Group type: EXPERIMENTAL
Intervention: Dextromethorphan/Quinidine (DM/Q)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 14606933

Group type: COMPARATOR
Intervention: Pimecrolimus (5-60mg single dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pimecrolimus (5-30mg multiple doses)
Number of subjects: 0
Study: 11049696

Group type: EXPERIMENTAL
Intervention: Low sodium diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (normal sodium diet)
Number of subjects: 24
Study: 8773820

Group type: EXPERIMENTAL
Intervention: Aftercare worker service
Number of subjects: 32
Study: 1475622

Group type: EXPERIMENTAL
Intervention: Enteric-coated piroxicam tablets (20 mg once daily for 2 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Plain piroxicam tablets (20 mg once daily for 2 weeks)
Number of subjects: 16
Study: 6383591

Group type: EXPERIMENTAL
Intervention: BCG immunotherapy (intradermaIly with a Heaf gun and orally for 2 years)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Routine follow-up (Control)
Number of subjects: 199
Study: 31717971

Group type: EXPERIMENTAL
Intervention: Active Gaming (AG)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Active Gaming with wrist‐worn weights (AGW)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Walking at 6 km/h (W6)
Number of subjects: 9
Study: 29941516

Group type: EXPERIMENTAL
Intervention: Renal Denervation (RDN)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 25953451

Group type: EXPERIMENTAL
Intervention: New Nordic Diet (NND)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Average Danish Diet (ADD)
Number of subjects: 132
Study: 24565019

Group type: EXPERIMENTAL
Intervention: Community Engagement (CE) activities
Number of subjects: 200
Study: 22887155

Group type: EXPERIMENTAL
Intervention: dealcoholized red wine (RWD) (272mL/day, polyphenol control)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: alcoholized red wine (RWA) (272mL/day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: gin (GIN) (100mL/day, alcohol control)
Number of subjects: 61
Study: 20054045

Group type: EXPERIMENTAL
Intervention: Mupirocin nasal ointment and chlorhexidine soap
Number of subjects: 917

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 917
Study: 17914136

Group type: EXPERIMENTAL
Intervention: 1.0g instant black tea
Number of subjects: 16

Group type: COMPARATOR
Intervention: 250ml of water (control)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 250ml of water plus 0.052g of caffeine (positive control)
Number of subjects: 16
Study: 16056171

Group type: EXPERIMENTAL
Intervention: Tailored intervention
Number of subjects: 124

Group type: COMPARATOR
Intervention: Nontailored intervention (Control)
Number of subjects: 124
Study: 12269760

Group type: EXPERIMENTAL
Intervention: Educational training program for hospital nurses on universal precautions
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no educational training)
Number of subjects: 50
Study: 10078398

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 52

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 52
Study: 8548111

Group type: EXPERIMENTAL
Intervention: Parenteral antiarrhythmics
Number of subjects: 0
Study: 1785181

Group type: EXPERIMENTAL
Intervention: Live recombinant influenza vaccine type A (H1N1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Live recombinant influenza vaccine type B
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bivaccine (combined A and B strains)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mono-vaccine (either A or B)
Number of subjects: 0
Study: 6269935

Group type: EXPERIMENTAL
Intervention: Timolol maleate
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 31881987

Group type: EXPERIMENTAL
Intervention: app + tailored messages
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: app + tailored messages + gamification I
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: app + tailored messages + gamification II
Number of subjects: 42

Group type: COMPARATOR
Intervention: physical activity counseling
Number of subjects: 42
Study: 29789267

Group type: EXPERIMENTAL
Intervention: Recovery (occlusion at 171-266mmHg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (occlusion at 15mmHg)
Number of subjects: 24
Study: 26728364

Group type: EXPERIMENTAL
Intervention: Molecular Adsorbents Recirculating System (MARS)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Single-Pass Albumin Dialysis (SPAD)
Number of subjects: 32
Study: 24956325

Group type: EXPERIMENTAL
Intervention: SG-IVR (small group intervention plus 12 months of interactive voice response telephone follow-up)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: DVD-IVR (DVD version of the small group intervention with the same IVR follow-up)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: SG (standard care, small group, diabetes prevention education class)
Number of subjects: 600
Study: 22148919

Group type: EXPERIMENTAL
Intervention: Achilles tendon vibration (1 h daily at 50 Hz for 14 days)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no vibration)
Number of subjects: 29
Study: 20650600

Group type: EXPERIMENTAL
Intervention: Prolonged exposure (PE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Supportive counseling (SC)
Number of subjects: 40
Study: 17230607

Group type: EXPERIMENTAL
Intervention: Yoga sessions biweekly for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 60
Study: 15109191

Group type: EXPERIMENTAL
Intervention: Patient-controlled sedation with midazolam (mean total dose 7.9 mg +/- 4.2 SD)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Operator-controlled sedation with midazolam (mean total dose 4.2 mg +/- 1.8 SD)
Number of subjects: 35
Study: 11553900

Group type: EXPERIMENTAL
Intervention: 950 micros pulsed CO(2) laser (UPCO(2))
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Variable pulsed erbium laser (VP Er:YAG)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Short pulse erbium laser
Number of subjects: 16
Study: 9683314

Group type: EXPERIMENTAL
Intervention: Short course (2 weeks) of systemic corticosteroids
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Long course (8 weeks) of systemic corticosteroids
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1100
Study: 8147323

Group type: EXPERIMENTAL
Intervention: Alcohol alone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cigarettes alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Alcohol plus cigarettes
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cigarettes with an energetic control
Number of subjects: 16
Study: 3364519

Group type: EXPERIMENTAL
Intervention: Base-in prism (8 delta, 12 delta)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Base-out prism (8 delta, 12 delta)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Base-in prism (4 delta)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Base-out prism (4 delta)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Prism glasses (3.0 to 6.7% performance decrement)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Denial of binocularity
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Reading and counting tasks
Number of subjects: 10
Study: 29112591

Group type: EXPERIMENTAL
Intervention: Landiolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Esmolol
Number of subjects: 12
Study: 28263256

Group type: EXPERIMENTAL
Intervention: Average daily step count
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Higher cardiorespiratory fitness
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: No fear/worry of falling
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Lower motor severity examination score
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: More recent time since Parkinson disease diagnosis
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Presence of a cardiovascular condition
Number of subjects: 128
Study: 27004324

Group type: EXPERIMENTAL
Intervention: Open haemorrhoidectomy (Milligan-Morgan technique)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Closed haemorrhoidectomy (Ferguson technique)
Number of subjects: 364
Study: 23595762

Group type: COMPARATOR
Intervention: 5 Hz rTMS to the right dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 39
Study: 21494892

Group type: EXPERIMENTAL
Intervention: Tapentadol IR 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tapentadol IR 75 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxycodone HCl IR 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18276017

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy (PT)
Number of subjects: 180
Study: 15145466

Group type: EXPERIMENTAL
Intervention: Letter fluency task ("KA", "TA" in "kana" script)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Category fluency task (ANIMAL, FRUIT)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Alogia symptoms (assessed by SANS)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Other domains of negative symptoms (assessed by SANS)
Number of subjects: 38
Study: 9925127

Group type: EXPERIMENTAL
Intervention: Daily supplementation (8 mg elemental Fe, 5 mg elemental Zn, 333 microg retinol, 20 mg vitamin C 5 d/wk for 3 mo)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Weekly supplementation (20 mg Fe, 17 mg Zn, 1700 microg retinol, 20 mg vitamin C once a week for 3 mo)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 7482713

Group type: EXPERIMENTAL
Intervention: Tacrolimus (FK506)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 322
Study: 2181223

Group type: EXPERIMENTAL
Intervention: ICRC anti-leprosy vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health Education (person-to-person approach)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preventive programmes backed by curative services
Number of subjects: 0
Study: 376132

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (procarbazine 100 mg/m2, Days 1‐‐10; vinblastine 5 mg/m2, Days 1 and 8; actinomycin D 0.5 mg/m2, Days 1 and 8)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Combination chemotherapy with MER (200 micrograms in five sites)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy
Number of subjects: 79

Group type: COMPARATOR
Intervention: Combination chemotherapy with MER
Number of subjects: 79
Study: 31887853

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg preoperatively
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Adductor canal block postoperatively
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 51
Study: 30811709

Group type: EXPERIMENTAL
Intervention: Metacognitive therapy
Number of subjects: 74

Group type: COMPARATOR
Intervention: Cognitive behavioural therapy
Number of subjects: 74
Study: 26094723

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg t.d.s for 12 weeks, along with prednisolone 40 mg o.d. tapered over 12 weeks.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clofazimine 100 mg t.d.s for 12 weeks, along with prednisolone 40 mg o.d. tapered over 12 weeks.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified, but receiving prednisolone).
Number of subjects: 20
Study: 24089075

Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22959555

Group type: EXPERIMENTAL
Intervention: 1-h infusion of 0.5 g doripenem every 8 hours for seven doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4-h infusion of 0.5 g doripenem every 8 hours for seven doses
Number of subjects: 0
Study: 19079316

Group type: EXPERIMENTAL
Intervention: PCR-based preemptive therapy (group A)
Number of subjects: 409

Group type: COMPARATOR
Intervention: Empirical antifungal therapy with liposomal amphotericin B (group B)
Number of subjects: 409
Study: 17321989

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 218

Group type: COMPARATOR
Intervention: Fluconazole
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 218
Study: 15073702

Group type: EXPERIMENTAL
Intervention: Warming garment (thermoregulation system)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Routine thermal care (control)
Number of subjects: 18
Study: 11192306

Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration (MUF)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (no MUF)
Number of subjects: 18
Study: 9682315

Group type: EXPERIMENTAL
Intervention: Questionnaire
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Opto-electric device
Number of subjects: 0
Study: 7745232

Group type: EXPERIMENTAL
Intervention: Intramuscular glucagon (GLU, 1 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Intravenous glucagon (GLU, 1 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Intravenous glucagon (GLU, 1 mg) with GHRH (1 microgram/kg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intramuscular glucagon (GLU, 1 mg) with GHRH (1 microgram/kg)
Number of subjects: 48
Study: 2498967

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ritanserin
Number of subjects: 0
Study: 31119419

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cyclobenzaprine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 28241785

Group type: EXPERIMENTAL
Intervention: Systematic pain assessment intervention with observational scales and training sessions.
Number of subjects: 164

Group type: COMPARATOR
Intervention: Comparison group with no systematic pain assessment, continued usual pain management.
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Nursing pain documentation practices.
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Nurse group interviews regarding pain assessments.
Number of subjects: 164
Study: 25984808

Group type: EXPERIMENTAL
Intervention: Health Promotion Program (HPP) for children with DCD (n = 22)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Health Promotion Program (HPP) for children without DCD (n = 19)
Number of subjects: 41
Study: 23994854

Group type: EXPERIMENTAL
Intervention: Fluctophoresis
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Mildronat fluctophoresis
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Nivaline fluctophoresis
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Acovegine fluctophoresis
Number of subjects: 160
Study: 21189374

Group type: EXPERIMENTAL
Intervention: Prostate-specific antigen (PSA) screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no PSA screening)
Number of subjects: 0
Study: 19339147

Group type: EXPERIMENTAL
Intervention: Counselor with better motivational interviewing (MI) skills
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Counselor with poorer MI skills
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Avoidance of MI‐inconsistent skills
Number of subjects: 95
Study: 17416207

Group type: EXPERIMENTAL
Intervention: Centrally measured ejection fraction
Number of subjects: 7016

Group type: COMPARATOR
Intervention: Investigator-measured ejection fraction
Number of subjects: 7016
Study: 15361500

Group type: EXPERIMENTAL
Intervention: CDP571 (10 mg/kg)
Number of subjects: 396

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: CDP571 (10 mg/kg) in patients with baseline CRP >=10 mg/l
Number of subjects: 396

Group type: COMPARATOR
Intervention: Placebo in patients with baseline CRP >=10 mg/l
Number of subjects: 396
Study: 11603594

Group type: EXPERIMENTAL
Intervention: Silzone valves
Number of subjects: 807

Group type: COMPARATOR
Intervention: Conventional valves
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: NA centers
Number of subjects: 807

Group type: COMPARATOR
Intervention: EU centers
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: Overall comparison
Number of subjects: 807
Study: 9844753

Group type: EXPERIMENTAL
Intervention: melatonin 5‐mg fast‐release (FR) formulation
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: melatonin 0.5‐mg fast‐release (FR) formulation
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: melatonin 2‐mg controlled‐release (CR) formulation
Number of subjects: 320

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 320
Study: 7986000

Group type: EXPERIMENTAL
Intervention: Ofloxacin (200 mg, every 12 h, orally for 5 days)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Ceftriaxone (3 g, once daily, intravenously for 3 days)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 47

Group type: COMPARATOR
Intervention: Ceftriaxone
Number of subjects: 47
Study: 2658458

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 200 mg x 3
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 31687079

Group type: EXPERIMENTAL
Intervention: Serum folate concentrations in women
Number of subjects: 5581

Group type: EXPERIMENTAL
Intervention: Dietary folate concentrations in women
Number of subjects: 5581

Group type: EXPERIMENTAL
Intervention: Serum vitamin B12 concentrations in women
Number of subjects: 5581

Group type: EXPERIMENTAL
Intervention: Dietary vitamin B12 concentrations in women
Number of subjects: 5581

Group type: COMPARATOR
Intervention: Men
Number of subjects: 5581
Study: 27572548

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 μg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 40
Study: 25457793

Group type: EXPERIMENTAL
Intervention: ENCOURAGE intervention (group-based lifestyle program)
Number of subjects: 0
Study: 23260750

Group type: EXPERIMENTAL
Intervention: n-3 fatty acid emulsion (0.2 g/kg) over 6 h for 3 consecutive days
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control (no n-3 fatty acid emulsion)
Number of subjects: 49
Study: 21785346

Group type: EXPERIMENTAL
Intervention: Conservative fluid protocol
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Liberal fluid protocol
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Patients meeting acute kidney injury criteria after adjustment for fluid balance
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Patients with acute kidney injury before but not after adjustment for fluid balance
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Patients meeting acute kidney injury criteria after but not before adjustment for fluid balance
Number of subjects: 1000
Study: 18496338

Group type: EXPERIMENTAL
Intervention: Active treatment (percutaneous radiofrequency neurotomy)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (sham treatment)
Number of subjects: 40
Study: 16890833

Group type: EXPERIMENTAL
Intervention: tipranavir-ritonavir
Number of subjects: 746

Group type: COMPARATOR
Intervention: CPI-ritonavir
Number of subjects: 746
Study: 15517441

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (3 MU/cm²)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (2 MU/cm²)
Number of subjects: 20
Study: 11766159

Group type: EXPERIMENTAL
Intervention: Auditory tones (500 Hz, range 54‐90 dB, 5‐sec duration)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham tone (recording with no tone)
Number of subjects: 11
Study: 9164808

Group type: EXPERIMENTAL
Intervention: Moderate-mineral formula (510 mg of calcium per liter and 390 mg of phosphorus per liter)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Moderate-mineral formula
Number of subjects: 101

Group type: COMPARATOR
Intervention: Human milk
Number of subjects: 101

Group type: COMPARATOR
Intervention: Low-mineral formula
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: High-mineral formula (1350 mg of calcium per liter and 900 mg of phosphorus per liter)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Cow milk (1230 mg of calcium per liter and 960 mg of phosphorus per liter)
Number of subjects: 101
Study: 8420273

Group type: EXPERIMENTAL
Intervention: Lemon-flavored Colyte
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard Colyte
Number of subjects: 56

Group type: COMPARATOR
Intervention: NuLYTELY
Number of subjects: 56
Study: 3090860

Group type: EXPERIMENTAL
Intervention: 600 mg DSCG rectally as enemas for eight weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (n = 22)
Number of subjects: 43
Study: 30356126

Group type: EXPERIMENTAL
Intervention: Vaginal brachytherapy (VBT)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Pelvic external beam radiotherapy (EBRT)
Number of subjects: 427
Study: 27178980

Group type: EXPERIMENTAL
Intervention: Remote care
Number of subjects: 60
Study: 24753014

Group type: EXPERIMENTAL
Intervention: Synthetic stable amorphous calcium carbonate (ACC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Crystalline calcium carbonate (CCC)
Number of subjects: 15
Study: 22629225

Group type: EXPERIMENTAL
Intervention: Supervised exercise program
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cyriax physiotherapy
Number of subjects: 20
Study: 20234364

Group type: EXPERIMENTAL
Intervention: CT+ZOL (neoadjuvant chemotherapy with zoledronic acid)
Number of subjects: 205

Group type: COMPARATOR
Intervention: CT (neoadjuvant chemotherapy)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: CT+ZOL
Number of subjects: 205

Group type: COMPARATOR
Intervention: CT
Number of subjects: 205